10.1002/adsc.202001033
Advanced Synthesis & Catalysis
2-Butyl-4-chloro-3-iodo-5-(p-tolyl)furan (5a): Colorless
3-yn-1ols should contribute to the synthetic toolbox
in the arsenal of synthetic methods. Our current
research efforts are directed to the synthetic utility of
,-dichloroallenyl ketones, and these results will be
reported in near future.
1
oil (301.7 mg, 81%); H-NMR (600 MHz, CDCl3): δ 7.76
(d, 2H, Ar-H, J = 8.40 Hz), 7.23 (d, 2H, Ar-H, J = 8.40
Hz), 2.74 (t, 2H, CH2(CH2)2CH3, J = 7.20 Hz), 2.37 (s, 3H,
Ar-CH3), 1.70-1.65 (m, 2H, CH2CH2CH2CH3), 1.43-1.37
(m, 2H, CH2CH2CH2CH3), 0.96 (t, 3H, (CH2)3CH3, J =
7.80 Hz); 13C-NMR (150 MHz, CDCl3): δ 155.6, 146.6,
137.8, 129.2, 126.5, 124.8, 115.2, 70.8, 30.0, 28.0, 22.1,
21.3, 13.8; HRMS (ESI): m/z calcd for C15H17ClIO
[(M+H)+] 375.0007, found 374.9995; IR (Neat, Thermo
Nicolet): 2956, 2928, 2871, 2860, 1588, 1558, 1501, 1464,
1457, 1107, 1088, 1020, 1014 cm-1.
Experimental Section
General Procedure for the Pd(TFA)2-Catalyzed 5-endo-
dig Cyclization
General Procedure for the Dehydrochlorinative
Iodination
Sodium borohydride (1 equiv., 1 mmol, 37.8 mg) was
added portion-wise to a solution of α,α-dichloropropargyl
ketone 1a (1 mmol, 283.2 mg) in anhydrous methanol (0.1
M, 10 mL) at 0 C, and the reaction mixture was stirred for
1 minute at the same temperature. After concentrating
under vacuum, the remaining residue was dissolved in
ethyl acetate (30 mL), washed with water and extracted
with ethyl acetate (30 mL x 2). The combined organic
layers were dried over anhydrous magnesium sulfate and
concentrated under reduced pressure. The resulting crude
compound 2a was used in the next step without
purification. After dissolving the compound 2a in
anhydrous THF (0.1 M, 10 mL), Pd(TFA)2 (5 mol%, 0.05
mmol, 16.6 mg) was added, and the reaction was stirred
under nitrogen at room temperature until the reaction was
complete by TLC (3 h). The reaction mixture was
concentrated in vacuo and purified by silica gel column
chromatography to provide 3a (eluent: Hexanes) in 83%
yield.
To a degassed 50 mL round bottom flask charged with 2,2-
dichlorobut-3-yn-1-ols 2a (1 mmol, 285.2 mg) and
anhydrous sodium sulfate (999.5 mg), anhydrous and
degassed acetonitrile (0.1 M, 10 mL) was added under
nitrogen followed by stirring at room temperature until the
complete dissolving of 2a. Sodium bicarbonate (3 equiv.,
3mmol, 251.9 mg) and N-iodosuccinimide (3 equiv.,
3mmol, 674.7 mg) were subsequently added and the
reaction was stirred at room temperature for 1 h under
nitrogen atmosphere. The reaction mixture color changed
gradually from colorless to yellow and then to deep brown.
After the compete conversion of 2a (monitored by TLC),
the reaction was quenched by adding saturated aqueous
sodium thiosulfate solution until the appearance of pale
yellow color. The reaction mixture was extracted using
ethyl acetate (30 mL x 3), washed with brine, dried over
anhydrous magnesium sulfate and then the solvent was
removed in vacuo to give the crude 6a as a yellowish
residue. Pure product 6a was obtained by silica gel column
chromatography using a mixture of hexanes and ethyl
acetate (v:v = 98:2) as yellow oil in 76% yield.
5-Butyl-3-chloro-2-(p-tolyl)furan (3a): Colorless oil
1
(206.2 mg, 83%); H-NMR (600 MHz, CDCl3): δ 7.77 (d,
2H, Ar-H, J = 8.40 Hz), 7.21 (d, 2H, Ar-H, J = 8.40 Hz),
6.07 (s, 1H, Furan-CH), 2.64 (t, 2H, CH2(CH2)2CH3, J =
7.80 Hz), 2.37 (s, 3H, Ar-CH3), 1.68-1.63 (m, 2H,
CH2CH2CH2CH3), 1.44-1.38 (m, 2H, CH2CH2CH2CH3),
0.95 (t, 3H, (CH2)3CH3, J = 7.20 Hz); 13C-NMR (150 MHz,
CDCl3): δ 154.9, 145.7, 137.1, 129.1, 127.2, 124.6, 110.9,
109.2, 29.9, 27.8, 22.2, 21.3, 13.8; HRMS (ESI): m/z calcd
for C15H18ClO [(M+H)+] 249.1041, found 249.1030; IR
(Neat, Thermo Nicolet): 2958, 2930, 2872, 2862, 1602,
1558, 1502 cm-1.
2-Chloro-4-iodo-1-(p-tolyl)octa-2,3-dien-1-one
(6a):
1
Yellow oil (85.8 mg, 76%); H-NMR (600 MHz, CDCl3):
δ 7.74 (d, 2H, Ar-H, J = 7.80 Hz), 7.28 (d, 2H, Ar-H, J =
7.80 Hz), 2.89 (t, 2H, CH2(CH2) 2CH3, J = 7.20 Hz), 2.42
(s, 3H, Ar-CH3), 1.51-1.46 (m, 2H, CH2CH2CH2CH3),
1.29-1.23 (m, 2H, CH2CH2CH2CH3), 0.86 (t, 3H,
(CH2)3CH3, J = 7.20 Hz); 13C-NMR (150 MHz, CDCl3): δ
197.2, 187.8, 146.1, 145.3, 130.9, 129.6, 129.5, 104.4, 41.4,
26.1, 21.9, 21.8, 13.7; HRMS (ESI): m/z calcd for
C15H17ClIO [(M+H)+] 375.0007, found 375.0014; IR (Neat,
Thermo Nicolet): 2958, 2930, 2871, 1678, 1605, 1543 cm-1.
General Procedure for the Pd(TFA)2-Catalyzed 5-endo-
dig Iodocyclization
α,α-Dichloropropargyl ketone 1a (1 mmol, 283.2 mg) was
dissolved in anhydrous methanol (0.1 M, 10 mL) under
nitrogen followed by the portion-wise addition of sodium
borohydride (1 equiv., 1 mmol, 37.8 mg) at 0 C. After 1
min stirring at the same temperature, methanol was
completely removed under vacuum and then the remaining
residues were dissolved in ethyl acetate (30 mL), washed
with water and further extracted with ethyl acetate (30 mL
x 2). After drying the combined organic layers using
anhydrous magnesium sulfate, the ethyl acetate was
completely evaporated under reduced pressure followed by
azeotropic drying using anhydrous toluene to provide a
fully dried crude alcohol 2a. The resulting crude alcohol
2a was dissolved in anhydrous THF (0.1 M, 10 mL) with
the addition of N-iodosuccinimide (1.1 equiv, 1.1 mmol,
247.5 mg) under nitrogen. The reaction mixture was stirred
until N-iodosuccinimide was completely dissolved (about 1
min), and then Pd(TFA)2 (5 mol%, 0.05 mmol, 16.6 mg)
was added to this solution. The reaction was stirred for 3 h
at room temperature and terminated by the dropwise
addition of aqueous saturated sodium thiosulfate until the
solution became pale-yellow. The crude product 5a was
extracted with ethyl acetate (30 mL x 3), washed with
brine and dried over magnesium sulfate. Purification by
silica gel column chromatography gave pure 5a (eluent:
Hexanes) in 81% yield.
Acknowledgements
This research was supported by the National Research
Foundation of Korea (NRF) grants funded by the Korean
government (MSICT) (NRF-2015R1A5A1008958, and NRF-
2019R1A2C2089953).
References
[1] For selected reviews, see: a) M. Z. Hernandes, S. M. T.
Cavalcanti, D. R. M. Moreira, W. F., Jr. de Azevedo, A.
C. L. Leite, Curr. Drug. Targets 2010, 11, 303-414; b)
E. Parisini, P. Metrangolo, T. Pilati, G. Resnati, G.
Terraneo, Chem. Soc. Rev. 2011, 40, 2267-2278; c) R.
Wilcken, M. O. Zimmermann, A. Lange, A. C. Joerger,
F. M. Boeckler, J. Med. Chem. 2013, 56, 1363-1388; d)
M. C. Ford, P. S. Ho, J. Med. Chem. 2016, 59, 1655-
1670; e) N. K. Shinada, A. G. de Brevern, P.
Schmidtke, J. Med. Chem. 2019, 62, 9341-9356.
[2] For selected examples, see: a) S. Arimitsu, B.
Fernández, C. del Pozo, S. Fustero, G. B. Hammond, J.
5
This article is protected by copyright. All rights reserved.